Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike

September 4, 2016

Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.

epipen alternative
Mark Baum / Imprimis Pharmceuticals

Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.

"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.

"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."


feel good videoDogs Are Forced To Wear The Things They Steal — And It’s Hilarious

feel good storiesJonathan And Nancy Fell In Love In Real Life — And So Did Their Stunt Doubles

feel good storiesThe Father Who Never Left His Son Behind

feel good storiesThis Restaurant's Dog Menu Is Almost As Fancy As The Human Menu

feel good storiesMan’s Best Friend: The Story Behind An Unforgettable Tomb In London

feel good storiesSenior Cat Labeled 'Sad And Scared' Finds Forever Home

feel good videoDogs Are Forced To Wear The Things They Steal — And It’s Hilarious

feel good videoTwo Humpback Whales Fall In Love With A Dog In Incredible Video

feel good videoVermont Trooper Jumps Into Frozen Pond To Save Child Trapped Under Ice

feel good videoHer Reaction To Getting The Baby Cow She’s Always Wanted Has Us All In Tears

feel good videoDonkey Opens Door, Then Waits Patiently To Be Let In For A Hug